- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsing Remitting Multiple Sclerosis (RRMS)
Total 3142 results
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Nantes University HospitalCompletedRelapsing-remitting Multiple SclerosisFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Universita di VeronaCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Claudio GobbiOspedale Civico, LuganoCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Claudio GobbiBayerTerminatedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
Coordinación de Investigación en Salud, MexicoCompleted
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, SwitzerlandCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Cantonal Hospital of St. GallenUnknownRelapsing-Remitting Multiple SclerosisSwitzerland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
Institute for Clinical ResearchUnknownRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
Universitätsklinikum Hamburg-EppendorfNeovii Biotech; Clinical Trial Center North (CTC North GmbH & Co. KG)TerminatedRelapsing-Remitting Multiple SclerosisGermany
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
BayerCompletedRelapsing-remitting Multiple SclerosisFrance
-
EMD SeronoWithdrawnRelapsing-Remitting Multiple Sclerosis
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisCanada, United States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
Charite University, Berlin, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsTerminatedRelapse Remitting Multiple SclerosisUnited States, Ukraine, Czechia
-
University Hospital, CaenCompletedRelapsing-Remitting Multiple SclerosisFrance
-
Institut National de la Santé Et de la Recherche...UnknownMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom, Ireland
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Thomas Jefferson UniversityRecruitingRelapse Remitting Multiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
University of MalagaUnknownRelapsing-remitting Multiple SclerosisSpain
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
Galapagos NVTerminatedClinically Isolated Syndrome | Acute Exacerbation of Remitting Relapsing Multiple SclerosisBelgium, Poland, Germany
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Banner Life Sciences LLCEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico